Market Report Service
Home About Us Industry Report Store Resources Contact us

Atrial Fibrillation Surgery Market (Latest Report) Size, Share and Analysis 2024-2030

Market Report Service

Rising incidence of AF worldwide and the rising demand for cutting-edge treatment options are the main driver of growth in the atrial fibrillation surgery market

The market for atrial fibrillation surgery is being driven by factors such as the rising incidence of AF worldwide, the ageing population, and the rising demand for cutting-edge treatment options. The market has expanded as a result of technological developments in surgical procedures and tools like catheter ablation and minimally invasive surgery.

The market's expansion has also been aided by the growing healthcare infrastructure, better reimbursement practices, and rising patient and healthcare professional awareness of the advantages of AF surgery. These elements work together to increase demand for AF surgical interventions and fuel the AF surgery market's expansion.

atrial fibrillation surgery market is expected to grow at 14.5% CAGR from 2023-2030 & predicted to reach above USD 5.85 billion by 2030 from USD 3.01 billion in 2023

Download Sample Report Now: https://marketreportservice.com/request-sample/atrial-fibrillation-surgery-market-54568

Competitive Landscape of the Atrial Fibrillation Surgery Market

  • Abbott Laboratories
  • AtriCure Inc.
  • BIOTRONIK SE and Co KG
  • Boston Scientific Corp.
  • CardioFocus Inc.
  • General Electric Healthcare
  • Johnson and Johnson
  • Medtronic Plc
  • Koninklijke Philips NV
  • Siemens Healthineers AG

New Developments in Atrial Fibrillation Surgery Market

04 August 2023 Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy

02 March 2023 Advantus Health Partners, and GE HealthCare (Nasdaq: GEHC), announced an agreement of up to USD 760M over 10-years to provide GE HealthCare’s Healthcare Technology Management (HTM) services to Advantus Health Partners’ clients.

high cost of surgical interventions is the major restraints for the atrial fibrillation surgery market

The market for atrial fibrillation (AF) surgery is constrained by the high cost of surgical interventions, potential risks and complications, limited access to specialised centres in some regions, and the preference for non-surgical treatment options.

Another market constraint might be patients' and medical professionals' limited understanding of AF surgery.

The atrial fibrillation surgery market offers several opportunities for growth

Opportunities in the atrial fibrillation (AF) surgery market include rising patient and healthcare professional awareness, expanding surgical techniques and technologies, rising AF treatment demand due to rising prevalence, and improvements in surgical methods and technologies.

Furthermore, opportunities for better outcomes and patient satisfaction are presented by the development of novel and minimally invasive surgical techniques.

COVID 19 had increased demand hybrid operating rooms

The market for atrial fibrillation (AF) surgery has been significantly impacted by the COVID-19 pandemic. Due to resource reallocation and safety concerns, elective surgeries, including AF surgeries, were postponed or cancelled. Procedure backlogs and fewer patient visits had an impact on market expansion.

However, the market is anticipated to pick up steam as healthcare systems improve and vaccination rates rise, driven by unmet demand for surgical treatments for AF.

Ambulatory surgical centre segment is anticipated to hold the largest market share in the atrial fibrillation surgery market based on end user

Due to improved healthcare infrastructure, the availability of skilled labour, and affordability, the ambulatory surgical centre segment is anticipated to experience healthy growth. The market is anticipated to be driven by an expanding patient base and an ageing population with lifestyle diseases like atherosclerosis and heart failure.

But compared to traditional surgeries, the advantages of minimally invasive procedures will eventually spur segment expansion. Benefits like lower surgical pain, injury risk, shorter hospital stays, improved accuracy, and quicker recovery times are pushing patients to choose minimally invasive procedures, which are expected to accelerate market expansion.

North America is dominating the global market for hybrid operating rooms

Due to the high prevalence of atrial fibrillation patients in the region, the North American segment is anticipated to hold a 38% market share during the forecast period of 2022–2030, dominating the atrial fibrillation surgery market. For instance, it was predicted that there would be between 2.7 million and 6.1 million atrial fibrillation patients in the US by 2022, and that number is expected to rise to 12.1 million by 2030. Other factors influencing the segment's growth include the region's favourable reimbursement policies and highly developed healthcare infrastructure.

Buy Complete Report https://marketreportservice.com/buy-now/54568

Open Surgery Heart Valve Market Growth Analysis Research Report segmented by Product Types (Mechanical Heart Valves, Bioprosthetic Heart Valves), by End-Users (Hospitals, Cardiac Surgery Centers), by Procedures (Closure of Atrial Septal Defect (ASD), Closure of Ventricle Septal Defect (VSD)) and by Color Visualization (Transesophageal Echocardiography (TEE), Intraoperative Fluoroscopy), and Regional Forecast till 2030

Embolotherapy Market Growth Analysis Report by Product (Embolic Agents (Microspheres, Embolic Coils Liquid Embolic Agents, Embolic Plug Systems, and Detachable Balloons), Support Devices (Microcatheters and Guidewires)), Procedure (Transcatheter Arterial Embolization (TAE), Selective Internal Radiation Therapy (SIRT), and Trans Arterial Chemoembolization (TACE)), End-User (Hospitals, Clinics, and Ambulatory Surgery Centers), and by Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa) Global Trends and Forecast from 2023 to 2030

Cardiac Surgery Instruments Market Research Analysis Report by Product (Forceps, Vascular Forceps, Grasping Forceps, Other Forceps, Needle Holders, Scissors, Clamps, Other), Application (Coronary Artery Bypass Graft (CABG), Heart Valve Surgery, Pediatric Cardiac Surgery, Other), End User (Hospitals and Cardiac Centers, Ambulatory Surgery Centers) and by Region Dynamics, Sales, Trends and Forecast from 2023-2030

Arthroscopy Instruments Market Research Report Analysis by Product (Arthroscopic Implants, Arthroscopes, Surgical Shavers, Fluid Management Systems, Visualization Systems, Radiofrequency (RF) Ablation Systems), by Application (Knee Arthroscopy, Shoulder Arthroscopy, Others), by End User (Hospitals, Ambulatory Surgery Centers & Clinics, Others) and Region, Global Trends and Forecast from 2023 to 2030

Endoscopic Spine Surgery Market Research Report Analysis by Product Type (Endoscopes, Endoscopic Devices), by Procedure type (Transforaminal Endoscopic Procedures, Interlaminar Endoscopic Procedures, Endoscopic Posterior Foraminotomy and Cervical Discectomy, Endoscopic Visualized Rhizotomy), by End User (Hospital and Clinics, Ambulatory Surgical Centers), and Region, Forecast till 2030

Micro-Invasive Glaucoma Surgery Devices Market by Type (Implants, Blink-assisted Devices,) Application (Hospital, Ophthalmology Clinics, Ambulatory Surgery Centers, Others,) and Region (North America, Europe, Asia Pacific, South America, Middle East and Africa), Global trends and forecast from 2023 to 2030

Select Licence Type


Single User

US$ 2499


Multi User

US$ 3499


Corporate User

US$ 4499

Only one user can access the report. It cannot be printed or shared. Delivery in online PDF.

US $ 2499

Multiple users can access the report. It cannot be printed or shared. Delivery in online PDF.

US $ 3499

The entire organization can use the report. It can be printed and shared. Delivery in PDF and Excel. Free update of the report after 1 year.

US $ 4499

Need a Discount? Get in touch with us for special pricing

Connect with our sales team